114 related articles for article (PubMed ID: 37201626)
1. COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells.
Zhang F; Li Q; Zhang Y; Li N; Rao M; Li S; Ai Z; Yan S; Tian Z
Eur J Pharmacol; 2023 Jul; 951():175799. PubMed ID: 37201626
[TBL] [Abstract][Full Text] [Related]
2. Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy.
Zhang F; Yan T; Guo W; Sun K; Wang S; Bao X; Liu K; Zheng B; Zhang H; Ren T
J Exp Clin Cancer Res; 2018 Jul; 37(1):135. PubMed ID: 29970115
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3.
Hong Y; Huang X; An L; Ye H; Ma K; Zhang F; Xu Q
Exp Cell Res; 2018 Apr; 365(2):163-170. PubMed ID: 29477618
[TBL] [Abstract][Full Text] [Related]
4. PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.
Yan S; Zhou N; Zhang D; Zhang K; Zheng W; Bao Y; Yang W
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671668
[TBL] [Abstract][Full Text] [Related]
5. RNAi-mediated COPS3 gene silencing inhibits metastasis of osteogenic sarcoma cells.
Yan T; Tang G; Ren T; Shen D; Sun K; Liang W; Guo W
Cancer Gene Ther; 2011 Jun; 18(6):450-6. PubMed ID: 21436869
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.
Zhu Z; Hong Y; Zhang F; An L; Yang Q; Huang X; Xu Q
Prostate; 2019 Dec; 79(16):1823-1831. PubMed ID: 31509289
[TBL] [Abstract][Full Text] [Related]
7. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.
Niu J; Yan T; Guo W; Wang W; Ren T; Huang Y; Zhao Z; Yu Y; Chen C; Huang Q; Lou J; Guo L
Autophagy; 2023 Jun; 19(6):1693-1710. PubMed ID: 36451342
[TBL] [Abstract][Full Text] [Related]
8. COPS3 Promotes Proliferation, Invasion, and EMT of Colorectal Cancer Cells by MEK/ERK Pathway.
Xie Y; Wei Z; Cheng C
Dis Markers; 2022; 2022():7594489. PubMed ID: 35903293
[TBL] [Abstract][Full Text] [Related]
9. ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation.
Deng X; Yi X; Deng J; Zou Y; Wang S; Shan W; Liu P; Zhang Z; Chen L; Hao L
Exp Cell Res; 2019 Dec; 385(2):111689. PubMed ID: 31678169
[TBL] [Abstract][Full Text] [Related]
10. Silencing of the COPS3 gene by siRNA reduces proliferation of lung cancer cells most likely via induction of cell cycle arrest and apoptosis.
Wang XM; Cui JW; Li W; Cai L; Song W; Wang GJ
Asian Pac J Cancer Prev; 2012; 13(3):1043-8. PubMed ID: 22631635
[TBL] [Abstract][Full Text] [Related]
11. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
[TBL] [Abstract][Full Text] [Related]
12. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
13. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
Du JY; Wang LF; Wang Q; Yu LD
Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
[TBL] [Abstract][Full Text] [Related]
14. TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis.
Zou L; Fang Y; He W
Mol Cell Probes; 2023 Jun; 69():101911. PubMed ID: 37003349
[TBL] [Abstract][Full Text] [Related]
15. COPS3 AS lncRNA enhances myogenic differentiation and maintains fast-type myotube phenotype.
He ZZ; Zhao T; Qimuge N; Tian T; Yan W; Yi X; Jin J; Cai R; Yu T; Yang G; Pang W
Cell Signal; 2022 Jul; 95():110341. PubMed ID: 35491006
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression.
Zheng WD; Zhou FL; Lin N
Genet Mol Res; 2015 Dec; 14(4):16872-9. PubMed ID: 26681033
[TBL] [Abstract][Full Text] [Related]
17. Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma.
Sun T; Zhong X; Song H; Liu J; Li J; Leung F; Lu WW; Liu ZL
Cell Death Dis; 2019 Apr; 10(4):298. PubMed ID: 30931932
[TBL] [Abstract][Full Text] [Related]
18. Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer.
Lu C; Qiao P; Sun Y; Ren C; Yu Z
Clin Transl Med; 2021 Apr; 11(4):e400. PubMed ID: 33931981
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human Osteosarcoma.
Both J; Wu T; Ten Asbroek AL; Baas F; Hulsebos TJ
Cytogenet Genome Res; 2016; 150(1):52-59. PubMed ID: 27846620
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting.
Ge X; Lyu P; Cao Z; Li J; Guo G; Xia W; Gu Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):1115-21. PubMed ID: 26093295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
